{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T21:40:07Z","timestamp":1744666807243,"version":"3.40.4"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"15","license":[{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,4,11]]},"abstract":"<jats:p>The high readmission rate of patients with chronic heart failure (HF) can cause waste of medical resources and economic losses. Establishing an effective HF readmission model can effectively alleviate medical pressure and improve the quality of treatment. In this study, we conducted a comprehensive analysis of clinical and laboratory data from 248 patients with chronic HF who received treatment at our medical center between January 2021 to January 2022. We also measured soluble CD40 ligand (sCD40L) levels to determine their association with readmission due to HF during follow-up. To analyze the data, we employed various statistical methods including one-way ANOVA, correlation analysis, univariate COX regression, and Least Absolute Shrinkage and Selection Operator COX regression. Using these techniques, we organized the data and constructed a predictive model that was both trained and validated. We developed a nomogram to assess the likelihood of readmission within 180 days for patients with chronic HF. Our findings revealed that monocytes, creatinine, sCD40L, and hypertension history were all independent risk factors for 180-day HF readmissions. Additionally, our model\u2019s AUC was 0.731 in the training dataset and 0.704 in the validation dataset. This study provides new insights for predicting readmission within 180 days for patients with chronic HF. And sCD40L is an important predictive indicator for readmission of HF patients within 180 days, and clinical doctors can develop appropriate treatment plans based on sCD40L.<\/jats:p>","DOI":"10.1097\/md.0000000000042134","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T21:00:48Z","timestamp":1744664448000},"page":"e42134","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Construction and evaluation of a 180-day readmission prediction model for chronic heart failure patients based on sCD40L"],"prefix":"10.1097","volume":"104","author":[{"given":"Peng","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Cardiology, Shaoxing People\u2019s Hospital, Shaoxing, Zhejiang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoya","family":"Zhai","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Shaoxing People\u2019s Hospital, Shaoxing, Zhejiang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yefei","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Shaoxing People\u2019s Hospital, Shaoxing, Zhejiang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liping","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Shaoxing People\u2019s Hospital, Shaoxing, Zhejiang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Shaoxing People\u2019s Hospital, Shaoxing, Zhejiang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Shaoxing People\u2019s Hospital, Shaoxing, Zhejiang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengjian","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Shaoxing People\u2019s Hospital, Shaoxing, Zhejiang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250414","first-page":"e876","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: executive summary: A report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines.","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"R2-20250414","doi-asserted-by":"crossref","first-page":"e008406","DOI":"10.1161\/CIRCHEARTFAILURE.121.008406","article-title":"Prevalence and incidence of heart failure among urban patients in China: A national population-based analysis.","volume":"14","author":"Wang","year":"2021","journal-title":"Circ Heart Fail"},{"key":"R3-20250414","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1161\/CIR.0000000000001052","article-title":"Heart disease and stroke statistics-2022 update: A report from the American Heart Association.","volume":"145","author":"Tsao","year":"2022","journal-title":"Circulation"},{"key":"R4-20250414","first-page":"1481","article-title":"Readmission risk prediction model for patients with chronic heart failure: A systematic review and meta-analysis.","volume":"51","author":"Liu","year":"2022","journal-title":"Iran J Public Health"},{"key":"R5-20250414","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fcvm.2017.00040","article-title":"CD40L and its receptors in atherothrombosis-an update.","volume":"4","author":"Michel","year":"2017","journal-title":"Front Cardiovasc Med"},{"key":"R6-20250414","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1515\/JPM.2008.082","article-title":"Premature labor: a state of platelet activation?","volume":"36","author":"Erez","year":"2008","journal-title":"J Perinat Med"},{"key":"R7-20250414","doi-asserted-by":"crossref","first-page":"8533","DOI":"10.3390\/ijms21228533","article-title":"CD40\/CD40L and related signaling pathways in cardiovascular health and disease-the pros and cons for cardioprotection.","volume":"21","author":"Daub","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R8-20250414","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.mvr.2018.11.009","article-title":"Evaluation of serum sST2 and sCD40L values in patients with microvascular angina.","volume":"122","author":"Aslan","year":"2019","journal-title":"Microvasc Res"},{"key":"R9-20250414","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.atherosclerosis.2020.12.011","article-title":"Soluble CD40 ligand expression in stable atherosclerosis: A systematic review and meta-analysis.","volume":"319","author":"Pereira-da-Silva","year":"2021","journal-title":"Atherosclerosis"},{"key":"R10-20250414","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/eurheartj\/ehi132","article-title":"Soluble CD40 ligand in acute and chronic heart failure.","volume":"26","author":"Ueland","year":"2005","journal-title":"Eur Heart J"},{"key":"R11-20250414","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jchf.2013.01.008","article-title":"Validated, electronic health record deployable prediction models for assessing patient risk of 30-day rehospitalization and mortality in older heart failure patients.","volume":"1","author":"Eapen","year":"2013","journal-title":"JACC Heart Fail"},{"key":"R12-20250414","doi-asserted-by":"crossref","first-page":"731730","DOI":"10.3389\/fcvm.2021.731730","article-title":"Development and validation of a nomogram to predict the 180-day readmission risk for chronic heart failure: A multicenter prospective study.","volume":"8","author":"Gao","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"R13-20250414","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.mayocpiqo.2022.04.002","article-title":"Predictive model for heart failure readmission using nationwide readmissions database.","volume":"6","author":"Zheng","year":"2022","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"R14-20250414","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1186\/s12955-020-01534-6","article-title":"A nomogram based on a patient-reported outcomes measure: predicting the risk of readmission for patients with chronic heart failure.","volume":"18","author":"Han","year":"2020","journal-title":"Health Qual Life Outcomes"},{"key":"R15-20250414","doi-asserted-by":"crossref","first-page":"E5556","DOI":"10.1073\/pnas.1801366115","article-title":"Role of CD40 and ADAMTS13 in von Willebrand factor-mediated endothelial cell-platelet-monocyte interaction.","volume":"115","author":"Popa","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R16-20250414","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nm0302-247","article-title":"CD40L stabilizes arterial thrombi by a beta3 integrin--dependent mechanism.","volume":"8","author":"Andr\u00e9","year":"2002","journal-title":"Nat Med"},{"key":"R17-20250414","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1056\/NEJMoa022600","article-title":"Soluble CD40 ligand in acute coronary syndromes.","volume":"348","author":"Heeschen","year":"2003","journal-title":"N Engl J Med"},{"key":"R18-20250414","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/MCA.0000000000000142","article-title":"Predictive value of elevated soluble CD40 ligand in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction.","volume":"25","author":"Pusuroglu","year":"2014","journal-title":"Coron Artery Dis"},{"key":"R19-20250414","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1093\/cvr\/cvz206","article-title":"Functional association of a CD40 gene single-nucleotide polymorphism with the pathogenesis of coronary heart disease.","volume":"116","author":"Sultan","year":"2020","journal-title":"Cardiovasc Res"},{"key":"R20-20250414","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.3390\/molecules27123715","article-title":"Effects of smoking on inflammatory-related cytokine levels in human serum.","volume":"27","author":"Wang","year":"2022","journal-title":"Molecules"},{"key":"R21-20250414","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1111\/j.1538-7836.2011.04415.x","article-title":"Prospective study of circulating soluble CD40 ligand concentrations and the incidence of cardiovascular disease in a nested prospective case-control study of older men and women.","volume":"9","author":"Jefferis","year":"2011","journal-title":"J Thromb Haemost"},{"key":"R22-20250414","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1093\/eurjhf\/hfr122","article-title":"The role of monocytes and inflammation in the pathophysiology of heart failure.","volume":"13","author":"Wrigley","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"R23-20250414","doi-asserted-by":"crossref","first-page":"103992","DOI":"10.1016\/j.ebiom.2022.103992","article-title":"Inflammation and resolution signaling in cardiac repair and heart failure.","volume":"79","author":"Halade","year":"2022","journal-title":"EBioMedicine"},{"key":"R24-20250414","doi-asserted-by":"crossref","first-page":"8395","DOI":"10.2147\/JIR.S461961","article-title":"Construction and comparison of multiple serum-based prognostic models for predicting the prognosis of acute exacerbations of chronic obstructive pulmonary disease.","volume":"17","author":"Wang","year":"2024","journal-title":"J Inflamm Res"},{"key":"R25-20250414","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.2147\/COPD.S416869","article-title":"Association of blood inflammatory biomarkers with clinical outcomes in patients with AECOPD: an 8-year retrospective study in Beijing.","volume":"18","author":"Shao","year":"2023","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"R26-20250414","doi-asserted-by":"crossref","first-page":"BSR20201108","DOI":"10.1042\/BSR20201108","article-title":"An elevated monocyte-to-high-density lipoprotein-cholesterol ratio is associated with mortality in patients with coronary artery disease who have undergone PCI.","volume":"40","author":"Zhang","year":"2020","journal-title":"Biosci Rep"},{"key":"R27-20250414","doi-asserted-by":"crossref","first-page":"108321","DOI":"10.1016\/j.compbiomed.2024.108321","article-title":"Predictive analytics for cardiovascular patient readmission and mortality: an explainable approach.","volume":"174","author":"Huberts","year":"2024","journal-title":"Comput Biol Med"},{"key":"R28-20250414","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/joim.13241","article-title":"Assessment of thirty-day readmission rate, timing, causes and predictors after hospitalization with COVID-19.","volume":"290","author":"Yeo","year":"2021","journal-title":"J Intern Med"},{"key":"R29-20250414","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jamcollsurg.2012.11.009","article-title":"Risk analysis for readmission after coronary artery bypass surgery: developing a strategy to reduce readmissions.","volume":"216","author":"Price","year":"2013","journal-title":"J Am Coll Surg"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042134","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T21:00:53Z","timestamp":1744664453000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,11]]},"references-count":29,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000042134","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,11]]}}}